The forecasted data indicates a gradual year-on-year increase in the number of new extrapulmonary tuberculosis cases in China from 2024 to 2028, with values rising from 45.64 thousand to 49.7 thousand cases. In 2023, the number stood at a lower level (actual value needed for precise comparison). The year-on-year growth from 2024 onwards is consistent, showcasing a steady incremental trend. The estimated CAGR over these five years highlights a sustained upward trajectory, reflecting ongoing challenges in controlling extrapulmonary tuberculosis.
Future trends to watch for include the impact of public health interventions, vaccine developments, and policy changes aimed at curbing TB incidence. Additionally, socioeconomic factors, urbanization, and healthcare access will influence these trends. Monitoring these elements will be crucial in strategizing effective TB management in China.
